MRCE for Biodefense and Emerging Infectious Dieseases

中西部地区生物防御和新发传染病研究卓越中心（MRCE）是中西部领先机构的联盟，将为第七区以及俄亥俄州部分地区的生物防御研究和培训需求提供服务。MRCE的成员包括圣路易斯的华盛顿大学（行政核心所在地）、凯斯西储大学、克利夫兰诊所/勒纳研究所、爱荷华州大学、圣路易斯大学、堪萨斯州立大学、爱荷华州州立大学、中西部研究所和密苏里州大学。MRCE的主要目标是利用来自最好机构的杰出科学家专注于生物防御和新兴传染病（EID）的关键问题。我们的目标是研究将对国家的公共卫生产生直接影响，并将为强大的生物防御努力提供科学基础。在上一个资助期间，MRCE通过创建一个跨机构的高度协作研究计划，改变了第七区的生物防御和EID研究，并导致了痘病毒，西尼罗河病毒和鼠疫的开创性发现。MRCE的新战略计划围绕两个研究主题。每个人的最终目标都是改善第七区和国家的生物准备。一个项目以病原体发现为中心，使用最先进的测序方法来识别新的和以前未被识别的生物威胁。这项工作有望帮助我们“了解我们的敌人”，提高我们开发针对危险病原体的诊断和治疗方法的能力。为了帮助制定应对这些威胁的对策，我们建议在分子水平上描述先天免疫系统如何控制病原微生物。我们的科学家将利用这些信息来开发刺激内源性宿主防御的方法，这些防御可以抵御多种生物威胁因子。支持MRCE战略计划的资源包括美国最大的测序中心华盛顿大学基因组测序中心、新的密苏里州大学RBL设施以及最先进的病原体发现设施。最后，MRCE将负责招募新的研究人员进行生物防御的临床和基础研究，并通过四个不同的职业发展计划培训他们如何安全可靠地进行这项研究。MRCE具有独特的地位，通过一个特殊的计划为第七区和国家服务，该计划解决了最直接和最紧迫的国家生物防御需求。

The Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases Research (MRCE) is a consortium of leading Midwest institutions that will serve the biodefense research and training needs for Region VII as well as parts of Ohio. The members of the MRCE are Washington University in St. Louis (site of the administrative core), Case Western Reserve University, Cleveland Clinic/Lerner Research Institute, the University of Iowa, St. Louis University, Kansas State University, Iowa State University, the Midwest Research Institute, and the University of Missouri. The major objective of the MRCE is to harness outstanding scientists from the best institutions to focus on critical issues in biodefense and emerging infectious diseases (EID). Our goal is research that will have an immediate impact on the nation's public health, and will provide the scientific base for a strong biodefense effort. During the previous funding period the MRCE transformed biodefense and EID research in Region VII by creating a highly collaborative research program that crossed institutions and led to seminal discoveries on poxviruses, West Nile Virus and plague. The new Strategic Plan for the MRCE centers on two research themes. Each has as their ultimate goal, improved biopreparedness for Region VII and the nation. One program centers on pathogen discovery, using state of the art sequencing approaches to identify new and previously unrecognized biologic threats. This work promises to help us "know our enemy", improving our ability to develop diagnostics and therapeutics against dangerous pathogens. To help develop countermeasures to these threats, we propose to delineate, at the molecular level, how the innate immune system controls pathogenic microorganisms. Our scientists will use this information to develop ways to stimulate endogenous host defenses that can protect against multiple biological threat agents. Resources supporting the MRCE Strategic Plan include the Washington University Genome Sequencing Center, the largest sequencing center in the United States, the new University of Missouri RBL facility, and new state of the art facilities for pathogen discovery. Finally, the MRCE will lead the effort to recruit new investigators to clinical and basic research in biodefense and train them in how to conduct this research safely and securely through four distinct Career Development Programs. The MRCE is uniquely positioned to serve Region VII and the nation through an exceptional program that addresses the most immediate and urgent national biodefense needs.